Secukinumab Associated Choroidal Neovascularization
<p>A previously healthy 38-year-old woman with non-radiographic spondyloarthritis (nrSpA) developed juxta-foveal Choroidal Neovascularization (CNV) in the right eye three months after starting treatment with the anti-IL-17A inhibitor secukinumab. As there was no sign of ocular inflammation, no...
Saved in:
Main Authors: | Edward B Miller (Author), Oren S Yovel (Author) |
---|---|
Format: | Book |
Published: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2022-03-09.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Arteriogenesis and Therapeutic Neovascularization
Published: (2020) -
Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
Published: (2020) -
Posterior Polar Hemispheric Choroidal Dystrophy
by: Shinji Makino
Published: (2015) -
Role of Radiation Therapy for Choroidal Hemangioma: A Brief Review
by: Kiran Turaka, et al.
Published: (2016) -
Paradoxical worsening of presumed tubercular serpiginous like choroiditis on anti-tubercular therapy
by: Priyanka1, et al.
Published: (2019)